Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to epstein-barr virus-associated T-cell lymphoproliferative disorder

Pediatric Critical Care Medicine

Volumn 14, Issue 4, 2013, Pages

  Nawathe, Pooja A ^a   Ravindranath, Thyyar M ^a   Satwani, Prakash ^a   Baird, J Scott ^a  

^a Columbia University ^*  (United States)

Author keywords

Coagulopathy; D dimer; Epstein Barr virus; Hemophagocytic lymphohistiocytosis; Lymphoproliferative disorder

Indexed keywords

ALEMTUZUMAB; AMINOCAPROIC ACID; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 7; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; D DIMER; DEXAMETHASONE; DIURETIC AGENT; ETOPOSIDE; FERRITIN; INOTROPIC AGENT; INTERLEUKIN 2 RECEPTOR; LACTATE DEHYDROGENASE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRIACYLGLYCEROL;

ABDOMINAL COMPARTMENT SYNDROME; ABDOMINAL DISTENSION; ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; BLEEDING; BLEEDING DISORDER; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CASE REPORT; CD8+ T LYMPHOCYTE; CHILD; CHILD HOSPITALIZATION; CLINICAL EXAMINATION; CONTINUOUS RENAL REPLACEMENT THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EPISTAXIS; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; FEMALE; FERRITIN BLOOD LEVEL; FEVER; FUNGAL SINUSITIS; HEMATEMESIS; HEMOPHAGOCYTIC SYNDROME; HEMOPTYSIS; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; HYPOFIBRINOGENEMIA; HYPOXEMIA; INSTITUTIONAL REVIEW; JAUNDICE; KIDNEY FAILURE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER BIOPSY; LUNG HEMORRHAGE; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE ORGAN FAILURE; MYOCARDIAL DISEASE; NOSE NECROSIS; ORAL BLEEDING; PANCREATITIS; PANCYTOPENIA; PARACENTESIS; PEDIATRIC HOSPITAL; PERICARDIAL EFFUSION; PETECHIA; PHARYNGITIS; PHENOTYPE; PLEURA EFFUSION; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; PULMONARY HYPERTENSION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SPLENOMEGALY; T LYMPHOCYTE; THROMBOCYTOPENIA; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FERRITINS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMORRHAGE; HEPATOMEGALY; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MULTIPLE ORGAN FAILURE; PANCYTOPENIA; RETROSPECTIVE STUDIES; SPLENOMEGALY; T-LYMPHOCYTES; VIRAL LOAD; YOUNG ADULT;

EID: 84877747127     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3182720f94     Document Type: Article

References (27)

1. Ohshima K, Kimura H, Yoshino T, et al: Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 2008; 58:209-217
2. Imashuku S: Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 2002; 44:259-272
3. Quintanilla-Martinez L, Kumar S, Fend F, et al: Fulminant EBV(+) T-cell lymphoproliferative disorder following acute/chronic EBV infection: A distinct clinicopathologic syndrome. Blood 2000; 96:443-451
4. Kikuta H: Epstein-Barr virus-associated hemophagocytic syndrome. Leuk Lymphoma 1995; 16:425-429
5. Henter JI, Horne A, Aricó M, et al: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124-131
6. Castillo L, Carcillo J: Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009; 10:387-392
7. Ho CH: Can very high level of d-dimer exclusively predict the presence of thromboembolic diseases? J Chin Med Assoc 2011; 74:151-154
8. Karapinar B, Yilmaz D, Balkan C, et al. An unusual cause of multiple organ dysfunction syndrome in pediatric intensive care unit: Hemophagocytic lymphohistiocytosis. Pediatr Crit Care Med 2009; 10:285-290
9. Taylor FB Jr, Toh CH, Hoots WK, et al: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-1330
10. Tierney LM Jr, Thabet A, Nishino H: Case records of the Massachusetts General Hospital. Case 10-2011. A woman with fever, confusion, liver failure, anemia, and thrombocytopenia. N Engl J Med 2011; 364:1259-1270
11. Stéphan JL, Koné-Paut I, Galambrun C, et al: Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001; 40:1285-1292
12. McClure PD, Strachan P, Saunders EF: Hypofibrinogenemia and thrombocytopenia in familial hemophagocytic reticulosis. J Pediatr 1974; 85:67-70
13. Bick RL, Baker WF: Diagnostic efficacy of the d-dimer assay in disseminated intravascular coagulation (DIC). Thromb Res 1992; 65:785-790
14. Shorr AF, Trotta RF, Alkins SA, et al: d-dimer assay predicts mortality in critically ill patients without disseminated intravascular coagulation or venous thromboembolic disease. Intensive Care Med 1999; 25:207-210
15. Kollef MH, Eisenberg PR, Shannon W: A rapid assay for the detection of circulating d-dimer is associated with clinical outcomes among critically ill patients. Crit Care Med 1998; 26:1054-1060
16. Shorr AF, Thomas SJ, Alkins SA, et al: d-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 2002; 121:1262-1268
17. Bevilacqua MP, Pober JS, Majeau GR, et al: Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-4537
18. Stouthard JM, Levi M, Hack CE, et al: Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996; 76: 738-742
19. van der Poll T, Levi M, Hack CE, et al: Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179:1253-1259
20. Nawroth PP, Handley DA, Esmon CT, et al: Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986; 83:3460-3464
21. Henter JI, Elinder G, Söder O, et al: Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78:2918-2922
22. Janka GE: Hemophagocytic syndromes. Blood Rev 2007; 21:245-253
23. Dalpke AH, Thomssen R, Ritter K: Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol 2003; 71:408-416
24. Bader MS, Haroon B, Trahey J, et al. Disseminated intravascular coagulation and venous thromboembolism due to acute Epstein-Barr virus infection. Infect Dis Clin Pract 2011; 19:284
25. Collen D: The plasminogen (fibrinolytic) system. Thromb Haemost 1999; 82:259-270
26. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
27. Kimura H: Pathogenesis of chronic active Epstein-Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 2006; 16:251-261